Abstract:Abstract Background: Trigeminal neuralgia is a typical kind of neuropathic pain featured with severe and recurrent pain attacks along the areas innervated by trigeminal nerve. Although mechanical injuries caused by vessels compression is highly related to the pathogenesis, the underlying molecular mechanism remains unclear. Methods: We constructed chronic constriction to infraorbital nerve (CCI) on Sprague Dawley rats, after which spontaneous pain and mechanical allodynia related behaviors were measured. Transcriptome of trigeminal ganglion (TG) affected by CCI were analyzed to select the related signaling pathway and genes. We examined the receptor-interacting serine/threonine-protein kinase 1 (RIPK1) and domain-like receptor protein 3 (NLRP3) expression in the trigeminal ganglion by western blotting and RT-PCR; studied the location of RIPK1 and NLRP3 expression by performing immunofluorescence. Necrostatin-1, the specific antagonist of RIPK1, was administered to identify the effect of RIPK1 inhibition on NLRP3 expression. Results: We identified mechanical allodynia within the whisker pad area after CCI. RNA-sequencing indicated that NLRP3 levels in the trigeminal ganglion were higher in CCI groups compared to the control group and MAPK signaling pathway was up-regulated after CCI. We also identified an increase in overall reactivity of RIPK1 in trigeminal ganglia after the surgery. A significant proportion of RIPK1+ cells in the TG of CCI rats colocalized with the neuron cells. RT-PCR result shows the expression of NLRP3 also increased following RIPK1 activation. The results from immunofluorescence staining revealed that NLRP3 was upregulated in TG neuron cells. Also, when RIPK1 is inhibited by Nec-1, NLRP3 expression in neurons from CCI rats also decreased. Nec-1 can alleviate the demyelination of TG and mechanical allodynia after CCI. Compared to control group, RIPK1 expression is down-regulated after Nec-1 injection, followed by a decreasing in NLRP3 expression. Conclusions: This study demonstrates RIPK1 in TG neurons is activated when nerves are mechanically injuried, leading to the over-expression of NLRP3 inflammasome by activating MAPK signaling pathway. The subsequent cascade of inflammatory feedback and pain signal transmission led to the occurrence of trigeminal neuralgia.

RIP3/MLKL pathway‐regulated necroptosis: A new mechanism of paclitaxel‐induced peripheral neuropathy

Inhibition of Receptor-Interacting Protein 3 Upregulation and Nuclear Translocation Involved in Necrostatin-1 Protection Against Hippocampal Neuronal Programmed Necrosis Induced by Ischemia/reperfusion Injury.

Spinal microglial M1 polarization contributes paclitaxel-induced neuropathic pain by triggering cells necroptosis

Activation of NLRP3 inflammasome in peripheral nerve contributes to paclitaxel-induced neuropathic pain

Necrostatin-1 Ameliorates Peripheral Nerve Injury-Induced Neuropathic Pain by Inhibiting the RIP1/RIP3 Pathway

Paclitaxel Inhibits KCNQ Channels in Primary Sensory Neurons to Initiate the Development of Painful Peripheral Neuropathy

Upregulation of NGF/TrkA-Related Proteins in Dorsal Root Ganglion of Paclitaxel-Induced Peripheral Neuropathy Animal Model

Phosphate NIMA-Related Kinase 2-Dependent Epigenetic Pathways in Dorsal Root Ganglion Neurons Mediates Paclitaxel-Induced Neuropathic Pain

Inhibition of Notch pathway Alleviates nab-Paclitaxel-Induced Peripheral Neuropathic Pain in Rats via Suppressing HMGB1/TLR4 Signaling in Spinal Cord

Roles of Thermosensitive Transient Receptor Channels TRPV1 and TRPM8 in Paclitaxel-Induced Peripheral Neuropathic Pain

RIPK1-mediated NLRP3 Activation Via MAPK Signaling Pathway in the Pathogenesis of Trigeminal Neuralgia

Protein Arginine Methyltransferase 5 Contributes to Paclitaxel-Induced Neuropathic Pain by Activating Transient Receptor Potential Vanilloid 1 Epigenetic Modification in Dorsal Root Ganglion

DNMT3b SUMOylation Mediated MMP-2 Upregulation Contribute to Paclitaxel Induced Neuropathic Pain

Dichotomy Between Receptor-Interacting Protein 1– and Receptor-Interacting Protein 3–mediated Necroptosis in Experimental Pancreatitis

Spinal HMGB1 participates in the early stages of paclitaxel-induced neuropathic pain via microglial TLR4 and RAGE activation

NET-Triggered NLRP3 Activation and IL18 Release Drive Oxaliplatin-Induced Peripheral Neuropathy

Inflammatory Stimulation Mediates Nucleus Pulposus Cell Necroptosis Through Mitochondrial Function Disfunction and Oxidative Stress Pathway

Differential Roles of RIPK1 and RIPK3 in TNF-induced Necroptosis and Chemotherapeutic Agent-Induced Cell Death.

Botulinum toxin type A-targeted SPP1 contributes to neuropathic pain by the activation of microglia pyroptosis

Proteomic Analysis of Dorsal Root Ganglia in a Mouse Model of Paclitaxel-Induced Neuropathic Pain

[miR-99b-5p inhibits the activation of NLRP3 inflammasome to alleviate the neurotoxicity induced by paclitaxel chemotherapy]